Volume 28, Number 9—September 2022
Dispatch
Sporadic Occurrence of Enteroaggregative Shiga Toxin–Producing Escherichia coli O104:H4 Similar to 2011 Outbreak Strain
Table
Overview of strains used in study of enteroaggregative Shiga toxin–producing Escherichia coli O104:H4 from the Netherlands*
Strain | Country | Source | Year | Reference/source |
---|---|---|---|---|
11-4632-C2 | France | Patient | 2011 | (13) |
11-3798 | Germany | Patient | 2011 | (13) |
11-02030 | Germany | Patient | 2011 | (13) |
11-02033 | Germany | Patient | 2011 | (13) |
11-02092 | Germany | Patient | 2011 | (13) |
11-02093 | Germany | Patient | 2011 | (13) |
11-02281 | Germany | Patient | 2011 | (13) |
11-06811 | Germany | Patient | 2011 | (14) |
F338 | Netherlands | Patient | 2013 | (8) |
381-1 | Netherlands | Patient | 2013 | (8) |
12-01621 | Germany | Long-term shedder | 2012 | † |
12-02462 | Germany | Long-term shedder | 2012 | † |
12-05378 | Germany | Long-term shedder | 2012 | † |
ESBL3427 | Netherlands | Pork | 2017 | † |
NL1981 | Netherlands | Patient | 2019 | † |
NL2076 | Netherlands | Patient | 2020 | † |
MRV-21-00239 | Austria | Patient | 2021 | † |
2015EL-1494M1 | United States | Human | NA | Enterobase |
TIAC1951 | Belgium | NA | 2003 | Enterobase |
09-7901 | France | NA | 2009 | Enterobase |
2012C-3196 | United States | NA | 2012 | Enterobase |
FORC_069 | South Korea | Human | 2016 | Enterobase |
PSU-0479 | South Korea | NA | 2000 | Enterobase |
NCCP15648 | South Korea | Human | 2001 | Enterobase |
1060_13 | United Kingdom | Human | 2014 | Enterobase |
55989 | Central African Republic | Human | 2002 | Enterobase |
201909204 | France | Human | 2019 | Enterobase |
216_13 | United Kingdom | Human | 2014 | Enterobase |
SCPM-O-B-9428 | Russia | Human | 2018 | Enterobase |
SCPM-O-B-9427 | Russia | Human | 2018 | Enterobase |
201600757 | France | Human | 2016 | Enterobase |
2011C-3907 | United States | NA | 2011 | Enterobase |
2012C-3808 | United States | Human | 2012 | Enterobase |
2014C-3008 | United States | NA | 2013 | Enterobase |
E90/11 | Germany | Human | 2011 | Enterobase |
GOS1 | NA | Human | 2011 | NCBI |
H112180541 | United Kingdom | Human | 2011 | NCBI |
H112180283 | United Kingdom | Human | NA | NCBI |
H112180540 | United Kingdom | Human | NA | NCBI |
11-02913 | Germany | Human | 2011 | Enterobase |
*NA, not available; NCBI, National Center for Biotechnology Information. †Genome sequence raw data files are available from the European Nucleotide Archive (projects PRJNA174138 and PRJEB49642).
References
- Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med. 2011;365:1763–70. DOIPubMedGoogle Scholar
- Scheutz F, Nielsen EM, Frimodt-Møller J, Boisen N, Morabito S, Tozzoli R, et al. Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill. 2011;16:19889. DOIPubMedGoogle Scholar
- Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis. 2011;11:671–6. DOIPubMedGoogle Scholar
- EFSA. Shiga toxin-producing E. coli (STEC) O104:H4 2011 outbreaks in Europe: taking stock. EFSA J. 2011;9:2390. DOIGoogle Scholar
- Jourdan-da Silva N, Watrin M, Weill FX, King LA, Gouali M, Mailles A, et al. Outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4 among French tourists returning from Turkey, September 2011. Euro Surveill. 2012;17:20065. DOIPubMedGoogle Scholar
- Frank C, Milde-Busch A, Werber D. Results of surveillance for infections with Shiga toxin-producing Escherichia coli (STEC) of serotype O104:H4 after the large outbreak in Germany, July to December 2011. Euro Surveill. 2014;19:20760. DOIPubMedGoogle Scholar
- Guy L, Jernberg C, Arvén Norling J, Ivarsson S, Hedenström I, Melefors Ö, et al. Adaptive mutations and replacements of virulence traits in the Escherichia coli O104:H4 outbreak population. PLoS One. 2013;8:
e63027 . DOIPubMedGoogle Scholar - Ferdous M, Zhou K, de Boer RF, Friedrich AW, Kooistra-Smid AM, Rossen JW. Comprehensive characterization of Escherichia coli O104:H4 isolated from patients in the Netherlands. Front Microbiol. 2015;6:1348. DOIPubMedGoogle Scholar
- Zhang W, Bielaszewska M, Kunsmann L, Mellmann A, Bauwens A, Köck R, et al. Lability of the pAA virulence plasmid in Escherichia coli O104:H4: implications for virulence in humans. PLoS One. 2013;8:
e66717 . DOIPubMedGoogle Scholar - Paradis E, Schliep K. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics. 2019;35:526–8. DOIPubMedGoogle Scholar
- Grad YH, Godfrey P, Cerquiera GC, Mariani-Kurkdjian P, Gouali M, Bingen E, et al. Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogen. MBio. 2013;4:e00452–12. DOIPubMedGoogle Scholar
- Okeke IN, Wallace-Gadsden F, Simons HR, Matthews N, Labar AS, Hwang J, et al. Multi-locus sequence typing of enteroaggregative Escherichia coli isolates from Nigerian children uncovers multiple lineages. PLoS One. 2010;5:
e14093 . DOIPubMedGoogle Scholar - Grad YH, Lipsitch M, Feldgarden M, Arachchi HM, Cerqueira GC, Fitzgerald M, et al. Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci U S A. 2012;109:3065–70. DOIPubMedGoogle Scholar
- Tietze E, Dabrowski PW, Prager R, Radonic A, Fruth A, Auraß P, et al. Comparative genomic analysis of two novel sporadic Shiga toxin-producing Escherichia coli O104:H4 strains isolated 2011 in Germany. PLoS One. 2015;10:
e0122074 . DOIPubMedGoogle Scholar
Page created: July 12, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.